Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: miyazaki s. Int J Hematol. 2001 Apr;73(3):369-77. doi: 10.1007/BF02981964. Int J Hematol. 2001. PMID: 11345205 Review.
Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A, Okamura J, Ishii E, Ikuno Y, Koga H, Eguchi H, Yanai F, Inada H, Nibu K, Hara T, Take H, Miyazaki S, Tasaka H. Matsuzaki A, et al. Among authors: miyazaki s. Pediatr Hematol Oncol. 1999 May-Jun;16(3):187-99. doi: 10.1080/088800199277245. Pediatr Hematol Oncol. 1999. PMID: 10326217 Clinical Trial.
Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: a report from the Kyushu-Yamaguchi Children's Cancer Study group in Japan.
Matsuzaki A, Eguchi H, Ikuno Y, Ayukawa H, Yanai F, Ishii E, Sugimoto T, Inada H, Anami K, Nibu K, Hara T, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: miyazaki s. Pediatr Hematol Oncol. 2000 Dec;17(8):623-34. doi: 10.1080/08880010050211330. Pediatr Hematol Oncol. 2000. PMID: 11127394 Clinical Trial.
Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan.
Tajiri T, Suita S, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Handa N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M; Committee for Pediatric Solid Malignant Tumors in the Kyushu Area. Tajiri T, et al. Among authors: miyazaki s. Cancer. 2001 Jul 15;92(2):349-53. doi: 10.1002/1097-0142(20010715)92:2<349::aid-cncr1329>3.0.co;2-c. Cancer. 2001. PMID: 11466689
Malignant germ cell tumors: clinical characteristics, treatment, and outcome. A report from the study group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S, Shono K, Tajiri T, Takamatsu T, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M; Committee for Pediatric Solid Malignant Tumors in the Kyushu Area. Suita S, et al. Among authors: miyazaki s. J Pediatr Surg. 2002 Dec;37(12):1703-6. doi: 10.1053/jpsu.2002.36700. J Pediatr Surg. 2002. PMID: 12483635
Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M; Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. Suita S, et al. Among authors: miyazaki s. J Pediatr Surg. 2004 Feb;39(2):195-8; discussion 195-8. doi: 10.1016/j.jpedsurg.2003.10.012. J Pediatr Surg. 2004. PMID: 14966739 Review.
2,736 results